BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T

Anbal-cel argeting DLBCL completes phase 2 trial Anticipation growing over Korea's first CAR-T therapy ahead of regulatory review Commerci...

November 02, 2023 | News

New report quantifies the impact of R&D Tax Incentive (RDTI) in Australia’s life sciences sector

The newly-launched ‘Economic impact of the Research & Development Tax Incentive for the biotech industry’, report has quantified the far-re...

November 01, 2023 | News

AusBiotech 2023 kicks off in Brisbane with 1,200 delegates representing global life science ecosystem

Held in Brisbane from 1-3 November, Australia’s biggest week in biotech features its flagship event, AusBiotech 2023, which today launches with more ...

November 01, 2023 | News

AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech

Australia’s biggest week is officially underway, with AusBioInvest 2023 kicking off today in Melbourne to an audience of investors and life sci...

October 30, 2023 | News

Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria

Biotium, a leading innovator of fluorescent dyes for life science research, proudly announces the launch of its breakthrough ...

October 26, 2023 | News

Lonza's Rapid PyroCell® Enhances Rabbit-Free Pyrogen Testing

Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems...

October 25, 2023 | News

CBC Healthcare Infrastructure Platform Secures US$875 Million with Mubadala Investment

Following the initial close in November 2021 and the successful closing of four projects, CBC HIP continues to generate substantial pipeline, and t...

October 23, 2023 | News

Waters Launches OligoWorks™ SPE Workflow and Kits for Faster Oligonucleotide Bioanalysis

Delivers up to 2x[i] higher oligonucleotide recovery from biofluids with improved LC-MS sensitivity and reproducibility to support robust quantitati...

October 23, 2023 | News

SOPHiA GENETICS Partners with MSKCC and AstraZeneca for Global Cancer Care Equality

SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with&...

October 19, 2023 | News

Thermo Fisher Scientific Acquires Next-Gen Proteomics Leader Olink

Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions Complements Existing...

October 18, 2023 | News

Ascentage Pharma & AstraZeneca Collaborate on Phase III Study for CLL/SLL Treatment

The two companies will jointly conduct a registrational Phase III study of the Bcl-2 inhibitor, APG-2575 (lisaftoclax), in combination with AstraZeneca's B...

October 16, 2023 | News

ABL Bio Achieves Regulatory Clearance for Innovative Bispecific Antibody in Solid Tumor; GenScript ProBio Commends Milestone Collaboration

ABL103 is a novel T-cell engaging bispecific antibody and demonstrates efficacious anti-tumor activity via B7-H4 mediated 4-1BB activation in tumor mi...

October 13, 2023 | News

Discovery Life Sciences Reveals Major Expansions: New Facilities, Tech, and Global Brand Upgrades

With support from the State of Alabama and HudsonAlpha, Discovery has opened its new 93,000-square-foot global headquarters building in ...

October 13, 2023 | News

MediLink and BioNTech Partner for Advanced Anti-Cancer Drug

Under the terms of the agreement, MediLink will grant BioNTech exclusive global rights for the development, manufacturing, and commercialization of one of ...

October 13, 2023 | News

Stay Connected